Die Grafik zeigt die prognostizierten Quartalsgewinne (Bereinigter Gewinn pro Aktie, EPS) und die tatsächlich erzielten Gewinne (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Umsatz (USD)
Schätzung
Umsatz
Die Grafik zeigt die prognostizierten Quartalsumsätze und die tatsächlich erzielten Umsätze (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Güte der Analystenschätzungen – EPS (aktueller Zeitraum)
Quartal / Datum
EPS (USD)
Schätzung (USD)
Abweichung
Quartal / Datum
Umsatz (Mio USD)
Schätzung (Mio USD)
Abweichung
Revisionen der Gewinnschätzungen
EPS-Schätzungen für die Geschäftsjahre
2027, 2028, 2029.
FREMONT, Calif., Nov. 17, 2026 /PRNewswire/ -- Lam Research Corp. (Nasdaq: LRCX) today announced that Tim Archer, President and Chief Executive Officer, and Doug Bettinger, Executive Vice President and Chief Financial Officer, will participate in the following upcoming investor event.
ASML and LRCX are riding AI-driven chip demand, but differences in growth prospects, valuation and earnings estimates make one a better investment pick.
Victoria Fernandez of Crossmark Global Investments, says the bull market is “not dead yet” and shares 10 stocks to buy now, including Nvidia, Broadcom, ASML and others. She also explains how much tech to own and what to expect from stocks heading into 2027.
ASML posted record revenue and still got hammered by sector-wide AI fears, with no company-specific bad news to blame. Why one bank sees far more upside than the consensus, and what could still derail the rebound, comes down to a few swing factors.
After a steep monthly slide, Cramer sees a bargain in the company that supplies the machines behind every AI chip. Record results and rising guidance back him up, but one China-sized risk could still derail the call.
I track 50 high-quality dividend growth stocks to identify favorable entry points, prioritizing long-term total return alongside a growing dividend stream. Forty stocks offer estimated future returns of at least 10%; 27 appear undervalued relative to historical free cash flow. ResMed leads with 41.60% estimated return potential; MarketAxess rose to fifth at 28.50% after a valuation upgrade and higher fair value estimate.
The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. RL, EXPE, NVDA and LRCX are some such stocks.
Portfolios
0
Zum Anlegen oder Bearbeiten von Portfolios müssen Sie sich anmelden oder einen Account erstellen.
Aktuelle Aktie in ein Portfolio speichern oder neues Portfolio anlegen: